companydata.dkcompanydata.dk

VetInject A/S: Financial statements 2018

CVR: 36949740

Source: annual report 2018, Danish Business Authority

01/12/2017 – 30/11/2018

VetInject A/S (CVR 36949740) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -141,024 and a net result of DKK -184,438 compared with DKK -148,145 the year before. Equity in the 2018 report amounted to DKK 89,711. The solvency ratio was 19.4%.

Gross Profit
DKK -141,024
Profit/Loss
DKK -184,438
Equity
DKK 89,711
Total Assets
DKK 463,525

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--141 t.-184 t.90 t.-
2017--120 t.-148 t.274 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Mikael Hans Andranik Hetting joins the board of VetInject A/SOct 26, 2018

As of October 26, 2018, Mikael Hans Andranik Hetting has joined the board of directors of VetInject A/S.

Emil Bue Bredel leaves the board of VetInject A/SOct 26, 2018

As of October 26, 2018, Emil Bue Bredel has left the board of directors of VetInject A/S.

Mikael Hans Andranik Hetting leaves the board of VetInject A/SOct 25, 2018

As of October 25, 2018, Mikael Hans Andranik Hetting has left the board of directors of VetInject A/S.

VetInject A/S: The 2017 annual report is outApr 17, 2018

VetInject A/S has published its annual report for 2017. Gross profit came to DKK -119,911, and the net result was DKK -148,145.

About VetInject A/S

VetInject A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2015. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named VetInject ApS and VET ApS. The management consists of Torben Helmer Knudsen. The board consists of John Holger Adamsen (chair), Carsten Sylvester Larsen and Torben Helmer Knudsen. The company is owned by Injecto Group A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -137,348 and a net result of DKK -171,903 compared with DKK -240,531 the year before. Equity in the 2025 report amounted to DKK 52,731.

Source: annual report 2025, Danish Business Authority

Other financial years